Investigational Site Number: 2500007

Toulouse 31059

1 studies enrolling now · 3 studies all time

What they study most

Asthma, Chronic Rhinosinusitis With Nasal Polyps, Hidradenitis Suppurativa

Studies at this site

• Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa — Recruiting now
• A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps — Running, not enrolling
• EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients — Completed